AvyaktaKallamMD

Hematologic Oncology

Physician

Dr. Kallam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2011 - 2014
Osmania Medical College NTR UHSClass of 2009

PubMed

54 citations
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, Jeffrey Barnes, Stefan K Barta
Journal of the National Comprehensive Cancer Network. 2022-03-01
306 citations
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
Kate Lynn E. Muir, Avyakta Kallam, Scott A. Koepsell, Krishna Gundabolu
The New England Journal of Medicine. 2021-04-14
52 citations
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow
Blood. 2021-09-27

Abstracts/Posters

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
Avyakta Kallam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Phase II multi-center study of ruxolitinib phosphate for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (...
2019 ASCO Annual Meeting - 6/1/2019